MNOW Stock Overview
Mednow Inc., a healthcare company, develops and operates a proprietary web application to facilitate the sale and distribution of prescription medications and the delivery of virtual care and telemedicine services in Canada.
Price History & Performance
|Historical stock prices|
|Current Share Price||CA$0.55|
|52 Week High||CA$2.90|
|52 Week Low||CA$0.52|
|1 Month Change||-25.68%|
|3 Month Change||-35.29%|
|1 Year Change||-74.42%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-88.42%|
Recent News & Updates
|MNOW||CA Online Retail||CA Market|
Return vs Industry: MNOW underperformed the Canadian Online Retail industry which returned -48.7% over the past year.
Return vs Market: MNOW underperformed the Canadian Market which returned 4.8% over the past year.
|MNOW Average Weekly Movement||12.0%|
|Online Retail Industry Average Movement||13.8%|
|Market Average Movement||9.8%|
|10% most volatile stocks in CA Market||17.0%|
|10% least volatile stocks in CA Market||4.4%|
Stable Share Price: MNOW is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: MNOW's weekly volatility (12%) has been stable over the past year.
About the Company
Mednow Inc., a healthcare company, develops and operates a proprietary web application to facilitate the sale and distribution of prescription medications and the delivery of virtual care and telemedicine services in Canada. It also owns and operates three retail pharmacies located in British Columbia, Ontario, and Nova Scotia. The company was incorporated in 2018 and is headquartered in Vancouver, Canada.
Mednow Fundamentals Summary
|MNOW fundamental statistics|
Is MNOW overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|MNOW income statement (TTM)|
|Cost of Revenue||CA$1.85m|
Last Reported Earnings
Jan 31, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.82|
|Net Profit Margin||-655.21%|
How did MNOW perform over the long term?See historical performance and comparison
Is Mednow undervalued compared to its fair value and its price relative to the market?
Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate MNOW's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate MNOW's fair value for valuation analysis.
Price To Earnings Ratio
PE vs Industry: MNOW is unprofitable, so we can't compare its PE Ratio to the North American Online Retail industry average.
PE vs Market: MNOW is unprofitable, so we can't compare its PE Ratio to the Canadian market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate MNOW's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: MNOW is good value based on its PB Ratio (0.5x) compared to the CA Online Retail industry average (1.3x).
How is Mednow forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Retail industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Mednow has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Mednow performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: MNOW is currently unprofitable.
Growing Profit Margin: MNOW is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: MNOW is unprofitable, and losses have increased over the past 5 years at a rate of 82.8% per year.
Accelerating Growth: Unable to compare MNOW's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: MNOW is unprofitable, making it difficult to compare its past year earnings growth to the Online Retail industry (-8.3%).
Return on Equity
High ROE: MNOW has a negative Return on Equity (-72.41%), as it is currently unprofitable.
How is Mednow's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Stable Cash Runway
Forecast Cash Runway
Financial Position Analysis
Short Term Liabilities: MNOW's short term assets (CA$20.5M) exceed its short term liabilities (CA$4.8M).
Long Term Liabilities: MNOW's short term assets (CA$20.5M) exceed its long term liabilities (CA$2.8M).
Debt to Equity History and Analysis
Debt Level: MNOW has more cash than its total debt.
Reducing Debt: Insufficient data to determine if MNOW's debt to equity ratio has reduced over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MNOW has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: MNOW has less than a year of cash runway if free cash flow continues to reduce at historical rates of 77.4% each year
What is Mednow current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Future Dividend Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate MNOW's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate MNOW's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if MNOW's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if MNOW's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as MNOW has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Karim Nassar (39 yo)
Mr. Karim Nassar, MBA is the Co-founder at Mednow Inc. and its Chief Executive Officer since April 1, 2020. Mr. Nassar joined Care Group of Pharmacies in 2019 as Vice President of Digital Strategy where he...
CEO Compensation Analysis
Compensation vs Market: Karim's total compensation ($USD158.35K) is about average for companies of similar size in the Canadian market ($USD168.83K).
Compensation vs Earnings: Insufficient data to compare Karim's compensation with company performance.
Experienced Management: MNOW's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Experienced Board: MNOW's board of directors are considered experienced (3.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: MNOW insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Mednow Inc.'s employee growth, exchange listings and data sources
- Name: Mednow Inc.
- Ticker: MNOW
- Exchange: TSXV
- Founded: 2018
- Industry: Internet and Direct Marketing Retail
- Sector: Retail
- Implied Market Cap: CA$11.863m
- Shares outstanding: 21.57m
- Website: https://www.mednow.ca
Number of Employees
- Mednow Inc.
- 4484 Main Street
- British Columbia
- V5V 3R3
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/23 00:00|
|End of Day Share Price||2022/05/19 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.